Literature DB >> 6110217

Differential effects of amphetamine and neuroleptics on negative vs. positive symptoms in schizophrenia.

B Angrist, J Rotrosen, S Gershon.   

Abstract

Positive symptoms of schizophrenia were diminished by neuroleptics and increased by amphetamine and accounted for most of the change seen in the total Brief Psychiatric Rating Scale (BPRS). Negative symptoms in the same subjects were not affected by neuroleptics but increased after amphetamines to a degree that just attained statistical significance. This increase was due to one item (emotional withdrawal) of the negative symptom factor which responded to neuroleptics and amphetamines as did positive symptoms. These findings are discussed with respect to new ideas about the role of dopamine in schizophrenia.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6110217     DOI: 10.1007/bf00433802

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  9 in total

Review 1.  The dopamine hypothesis of schizophrenia: a review.

Authors:  H Y Meltzer; S M Stahl
Journal:  Schizophr Bull       Date:  1976       Impact factor: 9.306

Review 2.  Molecular pathology of schizophrenia: more than one disease process?

Authors:  T J Crow
Journal:  Br Med J       Date:  1980-01-12

3.  Computerized EEG: predictor of outcome in schizophrenia.

Authors:  T M Itil; J Marasa; B Saletu; S Davis; A N Mucciardi
Journal:  J Nerv Ment Dis       Date:  1975-03       Impact factor: 2.254

4.  The dementia of dementia praecox.

Authors:  E C Johnstone; T J Crow; C D Frith; M Stevens; L Kreel; J Husband
Journal:  Acta Psychiatr Scand       Date:  1978-04       Impact factor: 6.392

5.  Research diagnostic criteria: rationale and reliability.

Authors:  R L Spitzer; J Endicott; E Robins
Journal:  Arch Gen Psychiatry       Date:  1978-06

6.  Cerebral ventricular size and cognitive impairment in chronic schizophrenia.

Authors:  E C Johnstone; T J Crow; C D Frith; J Husband; L Kreel
Journal:  Lancet       Date:  1976-10-30       Impact factor: 79.321

7.  Responses to apomorphine, amphetamine, and neuroleptics in schizophrenic subjects.

Authors:  B Angrist; J Rotrosen; S Gershon
Journal:  Psychopharmacology (Berl)       Date:  1980-01       Impact factor: 4.530

8.  Mechanism of the antipsychotic effect in the treatment of acute schizophrenia.

Authors:  E C Johnstone; T J Crow; C D Frith; M W Carney; J S Price
Journal:  Lancet       Date:  1978-04-22       Impact factor: 79.321

9.  Cerebral ventricular enlargement in chronic schizophrenia. An association with poor response to treatment.

Authors:  D R Weinberger; L B Bigelow; J E Kleinman; S T Klein; J E Rosenblatt; R J Wyatt
Journal:  Arch Gen Psychiatry       Date:  1980-01
  9 in total
  31 in total

1.  Landmark publications in Psychopharmacology: the first 40 years.

Authors:  K A Miczek
Journal:  Psychopharmacology (Berl)       Date:  2001-02       Impact factor: 4.530

Review 2.  Positive-negative symptom assessment in schizophrenia: psychometric issues and scale comparison.

Authors:  S R Kay
Journal:  Psychiatr Q       Date:  1990

3.  How treatment of persons with serious mental illness is portrayed in undergraduate psychology textbooks.

Authors:  C A Halter; G R Bond; R De Graaf-Kaser
Journal:  Community Ment Health J       Date:  1992-02

4.  Effect of adjuvant reserpine treatment on catecholamine metabolism in schizophrenic patients under long-term neuroleptic treatment.

Authors:  G Bagdy; A Perenyi; E Frecska; A Seregi; M I Fekete; L Tothfalusi; K Magyar; A Bela; M Arato
Journal:  J Neural Transm       Date:  1988       Impact factor: 3.575

Review 5.  Prefrontal cortex executive processes affected by stress in health and disease.

Authors:  Milena Girotti; Samantha M Adler; Sarah E Bulin; Elizabeth A Fucich; Denisse Paredes; David A Morilak
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2017-07-06       Impact factor: 5.067

Review 6.  The biology of schizophrenia.

Authors:  T J Crow
Journal:  Experientia       Date:  1982-11-15

Review 7.  A Developmental History of the Positive and Negative Syndrome Scale (PANSS).

Authors:  Stacy Liechti; Gianna Capodilupo; Douglas J Opler; Mark Opler; Lawrence H Yang
Journal:  Innov Clin Neurosci       Date:  2017-12-01

8.  Amphetamine response and relapse risk after depot neuroleptic discontinuation.

Authors:  B Angrist; E Peselow; M Rubinstein; A Wolkin; J Rotrosen
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

Review 9.  An Integrative Perspective on the Role of Dopamine in Schizophrenia.

Authors:  Tiago V Maia; Michael J Frank
Journal:  Biol Psychiatry       Date:  2016-06-01       Impact factor: 13.382

10.  Provocative tests with psychostimulant drugs in schizophrenia.

Authors:  J A Lieberman; J M Kane; J Alvir
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.